Optimization of the Targeted Anticancer Therapies

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2030

Conditions
Cancer
Interventions
BEHAVIORAL

Adherence program

This program combines adherence evaluation using an electronic monitor (MEMS®) and feedback with repeated medication adherence interviews with the pharmacist.

Trial Locations (1)

1011

RECRUITING

CHUV, Lausanne

All Listed Sponsors
collaborator

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

OTHER

collaborator

Krebsforschung Schweiz, Bern, Switzerland

OTHER

lead

Centre Hospitalier Universitaire Vaudois

OTHER